Internal Diseases – Part 1 (Rheumatology, Pulmonology, Phthisiatrics, Cardiology, Haematology) · MU Plovdiv

7. Bronchial asthma – management of asthma attacks, treatment of stable asthma

Inside: 15 sections · 4 labelled pictures · 2 tables · 29 flashcards · 14 min

Topic 12 of 68 in the MU Plovdiv syllabus for Internal Diseases – Part 1 (Rheumatology, Pulmonology, Phthisiatrics, Cardiology, Haematology) (Medicine, Year 4). The free AceMed note covers it in 15 sections, about 1,818 words (14 min of reading), with 29 flashcards.

In this note

  1. Essay 7- Bronchial asthma – management of asthma attacks, treatment of stable asthma
  2. Corticosteroids
  3. Selective B2 agonists
  4. Antimuscarinic drugs
  5. Methylxanthines
  6. Mast cell stabalizers
  7. Leukotriene modifiers
  8. Anti IgE drugs
  9. Treatment
  10. Asthma: epidemiology, pathogenesis, clinical features, diagnosis and differential diagnosis.
  11. Treatment of asthma.
  12. Introduction
  13. Key change (GINA since 2019)
  14. Stepwise treatment (GINA, adults, track 1 preferred)
  15. Rational prescribing points

Essay 7- Bronchial asthma – management of asthma attacks, treatment of stable asthma

  • Pharmacological drugs used

Corticosteroids

  • Pharmacokinetics
  • Inhalation is preferred
  • Can also be given parenterally
  • Pharmacodynamics
  • Stimulate synthesis of lipocortin which inhibits phospholipase A2
  • Inhibit prostaglandins, leukotriens, etc
  • (antiallergic, anti-inflammatory and immunosuppressant effects)
  • In patients with bronchial asthma they:
  • Suppress inflammatory response to Ag-Ab reaction
  • Decrease mucosal oedema
  • Reduce bronchial hyperreactivity
  • Theraputic uses
  • Control symptoms of bronchial asthma (“controllersˮ) & for asthmatic attacks
  • ADR
  • Local- oropharyngeal candiasis, dysphonia
  • These are ADRs for inhaled corticosteroids!!
  • Hyperglycemia
  • Gastric ulcer
  • Osteoporosis
  • Retention of sodium and water
  • Increased risk of infections (immunosupression)
  • Impaired wound healing
  • Increased intraocular pressure
  • Cataract
  • Adrenal suppression
  • Peripheral edema
  • Hypertension
  • Striae
  • Drug interactions
  • Potentiates the effects of β2adrenergic agonists
  • Often used in combination

Selective B2 agonists

  • Pharmacokinetics
  • A- given via inhalation
  • M- first pass metabolism in liver
  • Pharmacodynamics
  • Relax airway smooth muscles (bronchdilation)
  • By binding to B2 receptors in the bronchi
  • Theraputic uses
  • Short-acting- relieve symptoms of asthmatic attack (“relieversˮ)
  • Long-acting- to control symptoms of bronchial asthma between the attacks (“controllersˮ)
  • ADR
  • Tachycardia
  • Hyperglycemia
  • Finger tremor
  • Hypokalemia
  • Headache, agitation
  • Tolerance
  • Drug interactions
  • With tricyclic antidepressants, MAO inhibitors and thyroid hormones - increased risk of ADRs.
  • Beta blockers reduce the effect of β2 agonists.

Continue reading free

The whole note, all 15 sections, is free with an AceMed account, with its 29 flashcards. Premium adds flashcard recall, highlights and Ask AI.